Effects of aspirin and enoxaparin in a rat model of liver fibrosis

doi:10.3748/wjg.v23.i35.6412

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8092)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

599

WORD

204

HTML

4783

Figures (1-2)

236

Tables (1-3)

138

Sum=5960

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

815

Download

1317

Sum=2132

Sep 21, 2017 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Sep 21, 2017; 23(35): 6412-6419
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6412

Full Size Figure Download Figure

Figure 1 General observations of the rat model of liver fibrosis/cirrhosis. A: Healthy control group; B: TAA group; C: TAA + low-dose aspirin group; D: TAA + high-dose aspirin group; and E: TAA + enoxaparin group. TAA: Thioacetamide.

Citation: Li CJ, Yang ZH, Shi XL, Liu DL. Effects of aspirin and enoxaparin in a rat model of liver fibrosis. World J Gastroenterol 2017; 23(35): 6412-6419
URL: https://www.wjgnet.com/1007-9327/full/v23/i35/6412.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i35.6412